WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Leuprolide acetate

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.

    DOI: 10.1016/j.ajog.2023.02.029

    Source identity and connection checked by Codex (AI).

  2. Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better?

    DOI: 10.2217/fon-2023-1019

    Source identity and connection checked by Codex (AI).

  3. LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent Prostate Cancer.

    DOI: 10.1097/ju.0000000000003518

    Source identity and connection checked by Codex (AI).

  4. Leuprolide acetate: a drug of diverse clinical applications.

    DOI: 10.1517/13543784.16.11.1851

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Giunta EF
  • Gasperoni L
  • De Giorgi U
  • Foster KI
  • Flores Legarreta A
  • Kamat R
  • Handley KF
  • Glassman D
  • How JA
  • Lawson BC
  • Westin SN
  • Ramondetta LM
  • Frumovitz M
  • Gershenson DM
  • Sood AK
  • Hillman RT
  • Wilson AC
  • Meethal SV
  • Bowen RL
  • Atwood CS